PKP2

Clinical trials for PKP2 explained in plain language.

Never miss a new study

Get alerted when new PKP2 trials appear

Sign up with your email to follow new studies for PKP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental drug IC14 targets heart inflammation in rare disease

Disease control Completed

This early-phase trial tested a drug called IC14 in one person with arrhythmogenic cardiomyopathy, a rare heart condition that can cause dangerous heart rhythms. The goal was to see if the drug is safe and reduces inflammation, using blood tests and heart monitoring. The study di…

Matched conditions: PKP2

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated May 07, 2026 18:41 UTC

PKP2

Get alerted when new PKP2 trials appear

Experimental drug IC14 targets heart inflammation in rare disease